Clinical Trials Browser

Phase 2 × Rectal Neoplasms × Antiemetics × Clear all

NCT04296240 2020-03-05

Induction Chemotherapy for MRF-negative, Moderate-risk, Resectable Middle and Low Rectal Cancer

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms